Pub Date : 2024-01-01Epub Date: 2023-11-22DOI: 10.1177/02184923231216131
Abdessalem Hentati, Ahmed Ben Ayed, Jihen Jdidi, Zied Chaari, Ghassen Ben Halima, Imed Frikha
Background: Enhanced Recovery After Surgery (ERAS) applies multimodal, perioperative, and evidence-based practices to decrease postoperative morbi-mortality, the length of hospital stay, and hospitalization costs. Implementing enhanced recovery after thoracic surgery (ERATS) in low- and middle-income countries (LMIC) is problematic. This randomized controlled trial evaluated the feasibility and effectiveness of an ERATS protocol adapted to LMIC conditions in Tunisia.
Materials and methods: We conducted this randomized controlled trial between December 2015 and August 2017 in the Thoracic and Cardiovascular Surgery Department at Habib Bourguiba University Hospital of Sfax, Tunisia.
Results: One hundred patients undergoing thoracic surgery were randomly allocated to the ERATS group or Control group. During the postoperative phase, 13 patients (13%) were excluded secondary. These complication rates were lower in the ERATS group: lack of reexpansion (14.63% vs 16.10%: p = 0.72), pleural effusion (0% vs 10.86%, p = 0.05), and prolonged air leak (17.07% vs 30.43%, p = 0.14). The pain level decreased significantly in the ERATS group from postoperative H3 (p = 0.006). This difference was significant at H6 (p = 0.001), H24 (p = 0.05), H48 (p = 0.01), discharge (p = 0.002), and after 15 days (p = 0.01), with a decreased analgesic consumption. The length of hospital stay was shorter in the ERAS group (median six days vs seven days, p = 0.17).
Conclusion: This study provides an adapted ERATS protocol, applicable regardless of the surgical approach or the type of resection and suitable for LMIC hospital's conditions. This protocol can improve the postoperative outcomes of thoracic surgery.
背景:增强术后恢复(ERAS)应用多模式、围手术期和循证实践来降低术后发病率-死亡率、住院时间和住院费用。在低收入和中等收入国家(LMIC)实施胸外科手术后增强恢复(ERATS)是一个问题。这项随机对照试验评估了适用于突尼斯低收入国家条件的ERATS方案的可行性和有效性。材料和方法:我们于2015年12月至2017年8月在突尼斯斯法克斯Habib Bourguiba大学医院胸外科和心血管外科进行了这项随机对照试验。结果:100例胸外科手术患者随机分为ERATS组和对照组。在术后阶段,13例(13%)患者被排除为继发性。ERATS组并发症发生率较低:缺乏再扩张(14.63% vs 16.10%: p = 0.72),胸腔积液(0% vs 10.86%, p = 0.05),漏气时间延长(17.07% vs 30.43%, p = 0.14)。ERATS组疼痛水平较术后H3明显降低(p = 0.006)。这一差异在H6 (p = 0.001)、H24 (p = 0.05)、H48 (p = 0.01)、出院(p = 0.002)和15 d后(p = 0.01)均有统计学意义,镇痛药用量减少。ERAS组住院时间较短(中位数为6天vs 7天,p = 0.17)。结论:本研究提供了一个适应的ERATS方案,适用于任何手术入路或切除类型,适合LMIC医院的条件。该方案可提高胸外科手术的术后效果。
{"title":"Enhanced recovery after thoracic surgery in low- and middle-income countries: Feasibility and outcomes.","authors":"Abdessalem Hentati, Ahmed Ben Ayed, Jihen Jdidi, Zied Chaari, Ghassen Ben Halima, Imed Frikha","doi":"10.1177/02184923231216131","DOIUrl":"10.1177/02184923231216131","url":null,"abstract":"<p><strong>Background: </strong>Enhanced Recovery After Surgery (ERAS) applies multimodal, perioperative, and evidence-based practices to decrease postoperative morbi-mortality, the length of hospital stay, and hospitalization costs. Implementing enhanced recovery after thoracic surgery (ERATS) in low- and middle-income countries (LMIC) is problematic. This randomized controlled trial evaluated the feasibility and effectiveness of an ERATS protocol adapted to LMIC conditions in Tunisia.</p><p><strong>Materials and methods: </strong>We conducted this randomized controlled trial between December 2015 and August 2017 in the Thoracic and Cardiovascular Surgery Department at Habib Bourguiba University Hospital of Sfax, Tunisia.</p><p><strong>Results: </strong>One hundred patients undergoing thoracic surgery were randomly allocated to the ERATS group or Control group. During the postoperative phase, 13 patients (13%) were excluded secondary. These complication rates were lower in the ERATS group: lack of reexpansion (14.63% vs 16.10%: <i>p</i> = 0.72), pleural effusion (0% vs 10.86%, <i>p</i> = 0.05), and prolonged air leak (17.07% vs 30.43%, <i>p</i> = 0.14). The pain level decreased significantly in the ERATS group from postoperative H3 (<i>p</i> = 0.006). This difference was significant at H6 (<i>p</i> = 0.001), H24 (<i>p</i> = 0.05), H48 (<i>p</i> = 0.01), discharge (<i>p</i> = 0.002), and after 15 days (<i>p</i> = 0.01), with a decreased analgesic consumption. The length of hospital stay was shorter in the ERAS group (median six days vs seven days, <i>p</i> = 0.17).</p><p><strong>Conclusion: </strong>This study provides an adapted ERATS protocol, applicable regardless of the surgical approach or the type of resection and suitable for LMIC hospital's conditions. This protocol can improve the postoperative outcomes of thoracic surgery.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"27-35"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2023-12-03DOI: 10.1177/02184923231212657
Ramanish Ravishankar, Azar Hussain, Salman Arif, Tanveer Khan, Michael Gooseman, Vasileios Tentzeris, Michael Cowen, Syed Qadri
Introduction: The incidence of pneumonectomy for lung cancer in the UK is continuing to decline in the era of minimally invasive thoracic surgery totalling approximately 3.5% of lung cancer resections annually. Literature is lacking for long-term survival of pneumonectomies. This study updates our previous results. Between 1998 and 2008, 206 patients underwent pneumonectomy compared to 98 patients between 2009 and 2018.
Methods: From January 1998 until December 2018, 304 patients underwent pneumonectomy. This was a retrospective study; data was analysed for age, gender, laterality, histology and time period.
Results: Operative mortality was 4.3% overall which was lower than the national average of 5.8%. In the last five years, there were no in-hospital, operative or 30-day mortality. During this period, 90-day mortality was 9.2%. Left-sided pneumonectomies had significantly better overall survival (3.00 vs. 2.03 years; p = 0.0015), squamous cell carcinoma (3.23 vs. 1.54 years; p = 0.00012) as well as those aged less than 70 (2.79 vs. 2.13 years; p = 0.011). There was no significant difference in survival between gender (p = 0.48). Intervention from 1998 to 2008 had significantly greater survival compared to the latter 10 years (2.68 vs. 2.46 years; p = 0.031). The Cox model shows that laterality, age, histology and time period remain significant with multivariate testing. No patient survived after 16 years.
Discussion: Our updated retrospective study has built on our previous results by reinforcing the success of pneumonectomies. The incidence of pneumonectomies is likely to decrease with the deployment of nation-wide lung cancer screening in the UK due to earlier detection.
导读:在微创胸外科时代,英国肺癌全肺切除术的发生率持续下降,每年约占肺癌切除术的3.5%。文献缺乏关于肺切除术的长期生存。这项研究更新了我们以前的结果。1998年至2008年期间,206名患者接受了全肺切除术,而2009年至2018年期间为98名患者。方法:从1998年1月到2018年12月,304例患者接受了全肺切除术。这是一项回顾性研究;对数据进行年龄、性别、侧卧、组织学和时间段的分析。结果:手术死亡率为4.3%,低于全国平均水平5.8%。在过去五年中,没有住院、手术或30天内死亡。在此期间,90天死亡率为9.2%。左侧肺切除术的总生存期明显更好(3.00 vs 2.03年;P = 0.0015),鳞状细胞癌(3.23 vs. 1.54年;P = 0.00012),年龄小于70岁者(2.79 vs. 2.13;p = 0.011)。性别间生存率无显著差异(p = 0.48)。与后10年相比,1998 - 2008年干预的生存率显著提高(2.68年vs 2.46年;p = 0.031)。Cox模型显示,在多变量检验中,偏侧性、年龄、组织学和时间段仍然显著。16年后没有患者存活。讨论:我们最新的回顾性研究是建立在我们之前的研究结果的基础上,强调了肺切除术的成功。在英国,由于早期发现,随着全国范围内肺癌筛查的部署,肺切除术的发生率可能会降低。
{"title":"An analysis of long-term survival after pneumonectomy for lung cancer: A retrospective study of 20 years.","authors":"Ramanish Ravishankar, Azar Hussain, Salman Arif, Tanveer Khan, Michael Gooseman, Vasileios Tentzeris, Michael Cowen, Syed Qadri","doi":"10.1177/02184923231212657","DOIUrl":"10.1177/02184923231212657","url":null,"abstract":"<p><strong>Introduction: </strong>The incidence of pneumonectomy for lung cancer in the UK is continuing to decline in the era of minimally invasive thoracic surgery totalling approximately 3.5% of lung cancer resections annually. Literature is lacking for long-term survival of pneumonectomies. This study updates our previous results. Between 1998 and 2008, 206 patients underwent pneumonectomy compared to 98 patients between 2009 and 2018.</p><p><strong>Methods: </strong>From January 1998 until December 2018, 304 patients underwent pneumonectomy. This was a retrospective study; data was analysed for age, gender, laterality, histology and time period.</p><p><strong>Results: </strong>Operative mortality was 4.3% overall which was lower than the national average of 5.8%. In the last five years, there were no in-hospital, operative or 30-day mortality. During this period, 90-day mortality was 9.2%. Left-sided pneumonectomies had significantly better overall survival (3.00 vs. 2.03 years; <i>p</i> = 0.0015), squamous cell carcinoma (3.23 vs. 1.54 years; <i>p</i> = 0.00012) as well as those aged less than 70 (2.79 vs. 2.13 years; <i>p</i> = 0.011). There was no significant difference in survival between gender (<i>p</i> = 0.48). Intervention from 1998 to 2008 had significantly greater survival compared to the latter 10 years (2.68 vs. 2.46 years; <i>p</i> = 0.031). The Cox model shows that laterality, age, histology and time period remain significant with multivariate testing. No patient survived after 16 years.</p><p><strong>Discussion: </strong>Our updated retrospective study has built on our previous results by reinforcing the success of pneumonectomies. The incidence of pneumonectomies is likely to decrease with the deployment of nation-wide lung cancer screening in the UK due to earlier detection.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"11-18"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138478772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The bidirectional Glenn (BDG) shunt operation serves as temporary surgery for the treatment of single-ventricle physiology with the eventual Fontan procedure. In some cases, the procedure can be performed without the support of a cardiopulmonary bypass (CPB) machine. In this study, we present the surgical outcomes of off-pump BDG operation with the use of a temporary veno-atrial shunt to decompress the superior vena cava (SVC) during clamping time.
Methods: A cohort of 23 patients underwent off-pump BDG operations at Cardiovascular Center, E Hospital. All patients were operated on using a veno-atrial shunt to decompress the SVC.
Results: Satisfactory results with mean oxygen saturation increased from 79.6 ± 11.2% to 87.2 ± 4.7%. The SVC clamping time was 14 ± 2.4 min (ranging from 12 to 21 min). Among 23 patients, only six patients required blood transfusion, 17 patients had BDG without blood transfusion. No neurological complications or deaths occurred after the surgery, and the post-operative period was uneventful.
Conclusions: The use of veno-atrial shunts to decompress SVC during off-pump BDG operation is safe with good surgical outcomes and can avoid the deleterious effects caused by CPB. It is easily reproducible, at low cost and economically effective.
背景:双向Glenn (BDG)分流术是治疗单心室生理的临时手术,最终采用Fontan手术。在某些情况下,该过程可以在没有体外循环(CPB)机器支持的情况下进行。在这项研究中,我们介绍了在钳位期间使用临时静脉-心房分流器减压上腔静脉(SVC)的无泵BDG手术的手术结果。方法:选取在E医院心血管中心行非体外循环BDG手术的患者23例。所有患者均采用静脉-心房分流术对SVC进行减压。结果:结果满意,平均血氧饱和度由79.6±11.2%提高到87.2±4.7%。SVC夹紧时间为14±2.4 min (12 ~ 21 min)。23例患者中,仅6例患者需要输血,17例患者出现BDG,未输血。术后无神经系统并发症及死亡,术后平稳。结论:停泵BDG手术中采用静脉-心房分流术减压SVC是安全的,手术效果好,可避免CPB的不良影响。它易于复制,成本低,经济效益好。
{"title":"Bidirectional Glenn operation without cardiopulmonary bypass: Single center experience and results.","authors":"Tran Thuy Nguyen, Duc Hoang Nguyen, Tran-Chung Nguyen, Long Hoang Luong","doi":"10.1177/02184923231213010","DOIUrl":"10.1177/02184923231213010","url":null,"abstract":"<p><strong>Background: </strong>The bidirectional Glenn (BDG) shunt operation serves as temporary surgery for the treatment of single-ventricle physiology with the eventual Fontan procedure. In some cases, the procedure can be performed without the support of a cardiopulmonary bypass (CPB) machine. In this study, we present the surgical outcomes of off-pump BDG operation with the use of a temporary veno-atrial shunt to decompress the superior vena cava (SVC) during clamping time.</p><p><strong>Methods: </strong>A cohort of 23 patients underwent off-pump BDG operations at Cardiovascular Center, E Hospital. All patients were operated on using a veno-atrial shunt to decompress the SVC.</p><p><strong>Results: </strong>Satisfactory results with mean oxygen saturation increased from 79.6 ± 11.2% to 87.2 ± 4.7%. The SVC clamping time was 14 ± 2.4 min (ranging from 12 to 21 min). Among 23 patients, only six patients required blood transfusion, 17 patients had BDG without blood transfusion. No neurological complications or deaths occurred after the surgery, and the post-operative period was uneventful.</p><p><strong>Conclusions: </strong>The use of veno-atrial shunts to decompress SVC during off-pump BDG operation is safe with good surgical outcomes and can avoid the deleterious effects caused by CPB. It is easily reproducible, at low cost and economically effective.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"5-10"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138048053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Retrosternal gastric tube reconstruction is a common surgical technique for managing esophageal cancer, but it complicates acute type A aortic dissection repair and raises concerns about gastric tube damage.
Case presentation: A 73-year-old female, who underwent esophagectomy with retrosternal gastric tube reconstruction 6 months ago for esophageal cancer, presented with severe chest pain. Acute type A aortic dissection was confirmed by contrast-enhanced computed tomography, and emergency hemiarch replacement through a median sternotomy was performed, preserving the gastric tube without injury. The patient recovered well and was discharged after 3 weeks, showing no gastrointestinal symptoms or signs of mediastinitis.
{"title":"Acute type A aortic dissection surgery in retrosternal gastric tube reconstruction patient.","authors":"Nutthawadee Luangthong, Shin Yamamoto, Susumu Oshima, Tomohiro Hirokami, Kensuke Ozaki","doi":"10.1177/02184923231213429","DOIUrl":"10.1177/02184923231213429","url":null,"abstract":"<p><strong>Background: </strong>Retrosternal gastric tube reconstruction is a common surgical technique for managing esophageal cancer, but it complicates acute type A aortic dissection repair and raises concerns about gastric tube damage.</p><p><strong>Case presentation: </strong>A 73-year-old female, who underwent esophagectomy with retrosternal gastric tube reconstruction 6 months ago for esophageal cancer, presented with severe chest pain. Acute type A aortic dissection was confirmed by contrast-enhanced computed tomography, and emergency hemiarch replacement through a median sternotomy was performed, preserving the gastric tube without injury. The patient recovered well and was discharged after 3 weeks, showing no gastrointestinal symptoms or signs of mediastinitis.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"36-39"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71522842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-01Epub Date: 2023-10-16DOI: 10.1177/02184923231206237
Ryosuke Numaguchi, Jun Takaki, Kosaku Nishigawa, Takashi Yoshinaga, Toshihiro Fukui
Background: This study aimed to examine the clinical outcomes of mitral valve replacement (MVR) in patients with severe mitral annular calcification (MAC) who required extensive decalcification and mitral annular reconstruction.
Methods: We reviewed 15 patients with severe MAC who underwent MVR between January 2016 and May 2022. In all cases, the calcified mitral annulus was resected completely using a Cavitron Ultrasound Surgical Aspirator, and a new annulus was created using bovine pericardium. In the acute postoperative phase, strict afterload reduction therapy using an intra-aortic balloon pump (IABP) was administered.
Results: The mean age of patients was 73 ± 8 years, and 13 (86.7%) were women. Concomitant aortic valve replacement was performed in 11 (73.3%) patients, tricuspid annuloplasty in 9 (60.0%), coronary artery bypass grafting in 1 (6.7%), and arrhythmia surgery in 7 (46.7%). The mean aortic cross-clamp and cardiopulmonary bypass times were 143 ± 32 min and 175 ± 34 min, respectively. In 13 patients, an IABP was used for 2 or 3 days postoperatively. There were no in-hospital deaths, left ventricular ruptures, or other MAC-related complications. Postoperative echocardiography revealed no paravalvular leakages.
Conclusion: Our strategy for managing severe MAC is safe and reproducible even in relatively high-risk patients. Afterload reduction using an IABP in the acute postoperative phase may reduce the risk of fatal complications after extensive decalcification and mitral annular reconstruction.
{"title":"Outcomes of mitral valve replacement with complete annular decalcification.","authors":"Ryosuke Numaguchi, Jun Takaki, Kosaku Nishigawa, Takashi Yoshinaga, Toshihiro Fukui","doi":"10.1177/02184923231206237","DOIUrl":"10.1177/02184923231206237","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to examine the clinical outcomes of mitral valve replacement (MVR) in patients with severe mitral annular calcification (MAC) who required extensive decalcification and mitral annular reconstruction.</p><p><strong>Methods: </strong>We reviewed 15 patients with severe MAC who underwent MVR between January 2016 and May 2022. In all cases, the calcified mitral annulus was resected completely using a Cavitron Ultrasound Surgical Aspirator, and a new annulus was created using bovine pericardium. In the acute postoperative phase, strict afterload reduction therapy using an intra-aortic balloon pump (IABP) was administered.</p><p><strong>Results: </strong>The mean age of patients was 73 ± 8 years, and 13 (86.7%) were women. Concomitant aortic valve replacement was performed in 11 (73.3%) patients, tricuspid annuloplasty in 9 (60.0%), coronary artery bypass grafting in 1 (6.7%), and arrhythmia surgery in 7 (46.7%). The mean aortic cross-clamp and cardiopulmonary bypass times were 143 ± 32 min and 175 ± 34 min, respectively. In 13 patients, an IABP was used for 2 or 3 days postoperatively. There were no in-hospital deaths, left ventricular ruptures, or other MAC-related complications. Postoperative echocardiography revealed no paravalvular leakages.</p><p><strong>Conclusion: </strong>Our strategy for managing severe MAC is safe and reproducible even in relatively high-risk patients. Afterload reduction using an IABP in the acute postoperative phase may reduce the risk of fatal complications after extensive decalcification and mitral annular reconstruction.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"775-780"},"PeriodicalIF":0.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A 47-year-old man with a history of hypertension was found to have a prominent aortic knob on routine chest X-ray and was referred to our hospital. Enhanced computed tomography angiography showed severe flexion at the proximal descending aorta with chronic type B dissection localized to the flexion region. Graft replacement of the distal aortic arch was performed. Surgical management of chronic pseudocoarctation dissection is sparsely reported in the literature because of its rare occurrence. We present an operative case of a patient with chronic dissection of distal aortic arch pseudocoarctation.
{"title":"An operative case of pseudocoarctation with chronic dissection.","authors":"Masao Yoshitatsu, Yumi Kakizawa, Yusuke Misumi, Yukie Shirasaki, Mutsunori Kitahara, Hiroyuki Nishi","doi":"10.1177/02184923231205966","DOIUrl":"10.1177/02184923231205966","url":null,"abstract":"<p><p>A 47-year-old man with a history of hypertension was found to have a prominent aortic knob on routine chest X-ray and was referred to our hospital. Enhanced computed tomography angiography showed severe flexion at the proximal descending aorta with chronic type B dissection localized to the flexion region. Graft replacement of the distal aortic arch was performed. Surgical management of chronic pseudocoarctation dissection is sparsely reported in the literature because of its rare occurrence. We present an operative case of a patient with chronic dissection of distal aortic arch pseudocoarctation.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"805-808"},"PeriodicalIF":0.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-01Epub Date: 2023-10-25DOI: 10.1177/02184923231209364
Haralabos Parissis, Suhaib Ahmed, Jomanah Al Nasir, Jamal Khan, Mazen Ferwana
Objectives: Data on bilateral internal mammary artery (BIMA) versus single internal mammary artery (SIMA) on diabetics were analyzed; This is the only meta-analysis, the last 7 years.
Methods: Medline through PubMed/EMBASE/CINHAL and the Cochrane Central Register of Controlled Trials; 179 articles were studied; 19 studies deemed suitable and were included in the analysis.
Results: The mortality was 2.41% for BIMA versus 1.71% for SIMA (odds ratio [OR] = 0.95; 95% confidence interval [CI]: 0.74-1.22). Postoperative reopening for bleeding was higher at 3.75% for BIMA versus 2.91% for SIMA (OR = 1.49; 95% CI: 1.15-1.93). The incidence of MI was 0.87% for BIMA versus 0.83% for SIMA (OR = 0.73; 95% CI: 0.37-1.44). Deep sternal wound infection was 3.02% for BIMA and 1.95% for SIMA (OR = 1.57; 95% CI: 1.26-1.95). When skeletonized, the incidence of DSWI was 2.5% for BIMA versus 2.41% for SIMA. There was a significant difference at 5-year survival favoring the BIMA, 85.15% BIMA versus 80.77% SIMA (OR = 1.79; 95% CI: 1.60-2.01). The 10-year overall survival was 74.04% BIMA versus 61.57% SIMA (OR = 1.79; 95% CI: 1.61-1.98). The 15-year survival was 47.08% for BIMA versus 37.06% for SIMA (OR = 1.69; 95% CI: 1.52-1.88).
Conclusions: Postoperative bleeding was higher in BIMA group. Bilateral internal mammary artery in diabetic patients should be carried out in a skeletonize fashion, to reduce DSWI. There is a survival benefit of using BIMA in diabetics within 5 years of surgery; it remains significant up to 15 years.
{"title":"Bilateral versus single internal mammary artery in diabetic patients: systematic review and meta-analysis.","authors":"Haralabos Parissis, Suhaib Ahmed, Jomanah Al Nasir, Jamal Khan, Mazen Ferwana","doi":"10.1177/02184923231209364","DOIUrl":"10.1177/02184923231209364","url":null,"abstract":"<p><strong>Objectives: </strong>Data on bilateral internal mammary artery (BIMA) versus single internal mammary artery (SIMA) on diabetics were analyzed; This is the only meta-analysis, the last 7 years.</p><p><strong>Methods: </strong>Medline through PubMed/EMBASE/CINHAL and the Cochrane Central Register of Controlled Trials; 179 articles were studied; 19 studies deemed suitable and were included in the analysis.</p><p><strong>Results: </strong>The mortality was 2.41% for BIMA versus 1.71% for SIMA (odds ratio [OR] = 0.95; 95% confidence interval [CI]: 0.74-1.22). Postoperative reopening for bleeding was higher at 3.75% for BIMA versus 2.91% for SIMA (OR = 1.49; 95% CI: 1.15-1.93). The incidence of MI was 0.87% for BIMA versus 0.83% for SIMA (OR = 0.73; 95% CI: 0.37-1.44). Deep sternal wound infection was 3.02% for BIMA and 1.95% for SIMA (OR = 1.57; 95% CI: 1.26-1.95). When skeletonized, the incidence of DSWI was 2.5% for BIMA versus 2.41% for SIMA. There was a significant difference at 5-year survival favoring the BIMA, 85.15% BIMA versus 80.77% SIMA (OR = 1.79; 95% CI: 1.60-2.01). The 10-year overall survival was 74.04% BIMA versus 61.57% SIMA (OR = 1.79; 95% CI: 1.61-1.98). The 15-year survival was 47.08% for BIMA versus 37.06% for SIMA (OR = 1.69; 95% CI: 1.52-1.88).</p><p><strong>Conclusions: </strong>Postoperative bleeding was higher in BIMA group. Bilateral internal mammary artery in diabetic patients should be carried out in a skeletonize fashion, to reduce DSWI. There is a survival benefit of using BIMA in diabetics within 5 years of surgery; it remains significant up to 15 years.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"781-794"},"PeriodicalIF":0.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50158948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-01Epub Date: 2023-10-24DOI: 10.1177/02184923231209858
Alberto Pozzoli, Giuseppina Gabriella Surace, Tiziano Torre, Pietro Bagnato, Michele Gallo, Francesca Toto, Enrico Ferrari, Stefanos Demertzis
Background: The quality of a myocardial protection of a single-dose del Nido cardioplegia versus multiple dose blood-based cardioplegia on myocardial injury, outcomes and operative times in patients undergoing minimally invasive aortic valve replacement is basically unreported.
Methods and results: Preoperative and post-operative data, as well as technical details from isolated minimally invasive aortic valve replacements, performed using single-dose or multiple-dose cardioplegia were prospectively collected and retrospectively analysed. A total of 110 patients undergoing minimally invasive valve replacements at our institution composed two groups: 55 patients in the blood cardioplegia group (BloCa) and 55 in the del Nido group (DeNiCa). The two-matched groups were comparable in terms of preoperative variables. In the DeNiCa group, there was a statistically significant less need for cardiac defibrillation after aortic cross-clamp release (p < 0.001). Moreover, the BloCa group received intraoperatively more blood transfusions (p = 0.001) and more insulin administration for higher glucose levels (p < 0.001). The BloCa group showed higher intraoperative lactate levels (p = 0.01). Need for post-operative inotropic and vasoactive support, Creatine Kinase-MB levels after 6 and 12 h, onset of post-operative atrial fibrillation and length of stay were similar. No deaths occurred in neither groups.
Conclusion: Single-dose del Nido cardioplegia in the setting of minimally invasive aortic surgery seems to offer adequate myocardial protection, comparable to multiple dose hematic cardioplegia. It has been documented a lower peri-operative need of defibrillation after cross-clamp release, lactate- and glucose peak values, as well as less blood transfusions compared to blood cardioplegic strategy.
背景:在接受微创主动脉瓣置换术的患者中,单剂量del Nido停搏液与多剂量基于血液的停搏液对心肌损伤、结果和手术时间的心肌保护质量基本上没有报道。方法和结果:前瞻性收集和回顾性分析使用单剂量或多剂量心脏停搏液进行的孤立微创主动脉瓣置换术的术前和术后数据以及技术细节。我们机构共有110名接受微创瓣膜置换术的患者,分为两组:血液停搏液组(BloCa)55名患者和del Nido组(DeNiCa)55例患者。两个匹配组在术前变量方面具有可比性。在DeNiCa组中,主动脉阻断释放后对心脏除颤的需求在统计学上显著减少(p p = 0.001)和更多的胰岛素给药以获得更高的葡萄糖水平(p p = 0.01)。需要术后肌力和血管活性支持,6和12岁后肌酸激酶MB水平 h、 术后心房颤动的发作和住院时间相似。两组均未发生死亡。结论:在微创主动脉手术中,单剂量del Nido心脏停搏液似乎能提供足够的心肌保护,与多剂量血液停搏液相当。有文献表明,与血液心脏停搏液策略相比,交叉夹释放后的围手术期除颤需求更低,乳酸和葡萄糖峰值更低,输血更少。
{"title":"del Nido versus hematic cardioplegia in minimally invasive aortic valve surgery.","authors":"Alberto Pozzoli, Giuseppina Gabriella Surace, Tiziano Torre, Pietro Bagnato, Michele Gallo, Francesca Toto, Enrico Ferrari, Stefanos Demertzis","doi":"10.1177/02184923231209858","DOIUrl":"10.1177/02184923231209858","url":null,"abstract":"<p><strong>Background: </strong>The quality of a myocardial protection of a single-dose del Nido cardioplegia versus multiple dose blood-based cardioplegia on myocardial injury, outcomes and operative times in patients undergoing minimally invasive aortic valve replacement is basically unreported.</p><p><strong>Methods and results: </strong>Preoperative and post-operative data, as well as technical details from isolated minimally invasive aortic valve replacements, performed using single-dose or multiple-dose cardioplegia were prospectively collected and retrospectively analysed. A total of 110 patients undergoing minimally invasive valve replacements at our institution composed two groups: 55 patients in the blood cardioplegia group (BloCa) and 55 in the del Nido group (DeNiCa). The two-matched groups were comparable in terms of preoperative variables. In the DeNiCa group, there was a statistically significant less need for cardiac defibrillation after aortic cross-clamp release (<i>p</i> < 0.001). Moreover, the BloCa group received intraoperatively more blood transfusions (<i>p</i> = 0.001) and more insulin administration for higher glucose levels (<i>p</i> < 0.001). The BloCa group showed higher intraoperative lactate levels (<i>p</i> = 0.01). Need for post-operative inotropic and vasoactive support, Creatine Kinase-MB levels after 6 and 12 h, onset of post-operative atrial fibrillation and length of stay were similar. No deaths occurred in neither groups.</p><p><strong>Conclusion: </strong>Single-dose del Nido cardioplegia in the setting of minimally invasive aortic surgery seems to offer adequate myocardial protection, comparable to multiple dose hematic cardioplegia. It has been documented a lower peri-operative need of defibrillation after cross-clamp release, lactate- and glucose peak values, as well as less blood transfusions compared to blood cardioplegic strategy.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"795-801"},"PeriodicalIF":0.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50158950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: To evaluate the impact of chronic total occlusion (CTO) lesions on the patency of bypass grafts to the right coronary artery territory.
Methods: Two hundred patients undergoing primary isolated coronary artery bypass grafting with revascularization to the right coronary artery territory between April 2015 and July 2022 were retrospectively analyzed. Study patients were divided into two groups according to their right coronary artery lesion: patients with CTO lesions (n = 76) and those without CTO lesions (n = 124). Graft flow of the right coronary artery territory was evaluated by intraoperative transit time flow measurement and patency of the bypass graft was evaluated by multidetector row computed tomography.
Results: A total of 200 patients (76 patients with CTO and 124 patients without CTO) were included in this study. Intraoperative transit time flow measurement demonstrated that there was no significant difference in the median mean graft flow (30 ml/min vs. 25 ml/min; p = 0.114), pulsatility index (2.1 vs. 2.4; p = 0.079), and diastolic filling rate (65% vs. 64%; p = 0.844) between patients with CTO and those without CTO. Postoperative multidetector row computed tomography demonstrated that the patency of bypass grafts to the right coronary artery territory was similar between the groups (94.7% in patients with CTO vs. 96.0% in those without CTO; p = 0.733). In patients with CTO, the patency of bypass graft tended to be worse in subgroup with rich collateral blood flow (Rentrop grade 3).
Conclusions: Chronic total occlusion lesions do not affect the patency of bypass grafts to the right coronary artery territory.
{"title":"Do chronic total occlusive lesions affect patency of coronary bypass grafts to the right coronary artery?","authors":"Kosaku Nishigawa, Tatsuya Horibe, Hideaki Hidaka, Ryosuke Numaguchi, Jun Takaki, Takashi Yoshinaga, Toshihiro Fukui","doi":"10.1177/02184923231205967","DOIUrl":"10.1177/02184923231205967","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the impact of chronic total occlusion (CTO) lesions on the patency of bypass grafts to the right coronary artery territory.</p><p><strong>Methods: </strong>Two hundred patients undergoing primary isolated coronary artery bypass grafting with revascularization to the right coronary artery territory between April 2015 and July 2022 were retrospectively analyzed. Study patients were divided into two groups according to their right coronary artery lesion: patients with CTO lesions (<i>n</i> = 76) and those without CTO lesions (<i>n</i> = 124). Graft flow of the right coronary artery territory was evaluated by intraoperative transit time flow measurement and patency of the bypass graft was evaluated by multidetector row computed tomography.</p><p><strong>Results: </strong>A total of 200 patients (76 patients with CTO and 124 patients without CTO) were included in this study. Intraoperative transit time flow measurement demonstrated that there was no significant difference in the median mean graft flow (30 ml/min vs. 25 ml/min; <i>p</i> = 0.114), pulsatility index (2.1 vs. 2.4; <i>p</i> = 0.079), and diastolic filling rate (65% vs. 64%; <i>p</i> = 0.844) between patients with CTO and those without CTO. Postoperative multidetector row computed tomography demonstrated that the patency of bypass grafts to the right coronary artery territory was similar between the groups (94.7% in patients with CTO vs. 96.0% in those without CTO; <i>p</i> = 0.733). In patients with CTO, the patency of bypass graft tended to be worse in subgroup with rich collateral blood flow (Rentrop grade 3).</p><p><strong>Conclusions: </strong>Chronic total occlusion lesions do not affect the patency of bypass grafts to the right coronary artery territory.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"768-774"},"PeriodicalIF":0.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41138738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-01Epub Date: 2023-09-20DOI: 10.1177/02184923231203109
Daisuke Takeyoshi, Takeshi Konuma, Ai Kojima, Takamasa Takeuchi
A one-month-old baby boy with a complete atrioventricular septal defect underwent pulmonary artery banding. A high take-off of the left coronary artery, overlooked on the echocardiogram, was identified. It was compressed by the right pulmonary artery that was dilated owing to pulmonary artery banding. The patient developed severe heart failure, and a Lecompte maneuver was performed. The procedure helped effectively treat this congenital heart disease with a high take-off coronary artery compressed by the right pulmonary artery.
{"title":"Lecompte maneuver for compressed left coronary artery after pulmonary artery banding.","authors":"Daisuke Takeyoshi, Takeshi Konuma, Ai Kojima, Takamasa Takeuchi","doi":"10.1177/02184923231203109","DOIUrl":"10.1177/02184923231203109","url":null,"abstract":"<p><p>A one-month-old baby boy with a complete atrioventricular septal defect underwent pulmonary artery banding. A high take-off of the left coronary artery, overlooked on the echocardiogram, was identified. It was compressed by the right pulmonary artery that was dilated owing to pulmonary artery banding. The patient developed severe heart failure, and a Lecompte maneuver was performed. The procedure helped effectively treat this congenital heart disease with a high take-off coronary artery compressed by the right pulmonary artery.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"802-804"},"PeriodicalIF":0.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41144625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}